Dr. Kenneth Ruggiero, PhD
Claim this profileClinical Trials Kenneth Ruggiero, PhD is currently running
More about Kenneth Ruggiero, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kenneth Ruggiero, PhD has experience with
- Trauma Resilience And Recovery Program
Breakdown of trials Kenneth Ruggiero, PhD has run
Post-Traumatic Stress Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth Ruggiero, PhD specialize in?
Kenneth Ruggiero, PhD focuses on Post-Traumatic Stress Disorder and Depression. In particular, much of their work with Post-Traumatic Stress Disorder has involved treating patients, or patients who are undergoing treatment.
Is Kenneth Ruggiero, PhD currently recruiting for clinical trials?
Yes, Kenneth Ruggiero, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Kenneth Ruggiero, PhD has studied deeply?
Yes, Kenneth Ruggiero, PhD has studied treatments such as Trauma Resilience and Recovery Program.
What is the best way to schedule an appointment with Kenneth Ruggiero, PhD?
Apply for one of the trials that Kenneth Ruggiero, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.